Heng-Huan Lee

7PUBLICATIONS
46CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer.

|Aug 22, 2025
SOX11 modulates BCR signaling through the PAX5/CD19 axis for therapeutic targeting in BTK-resistant mantle cell lymphoma.

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V Leshchenko

|Jul 23, 2025
TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma.

Wei Wang, Qingsong Cai, Yang Liu

|Feb 02, 2024
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.

Chunxiao Liu, Chenhao Zhou, Weiya Xia

|May 31, 2023
Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma.

Yuxuan Che, Yang Liu, Yijing Li

|Oct 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.

Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei

Pageof 2

Frequent Collaborators

4 joint publications

Ying-Nai Wang

4 joint publications

Mien-Chie Hung

3 joint publications

Michael Wang

3 joint publications

Shao-Chun Wang